• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疫苗为何以及如何发挥作用。

Why and How Vaccines Work.

机构信息

Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA; Department of Molecular Cellular and Developmental Biology, Yale University, New Haven, CT 06510, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA.

Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06520, USA; Department of Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT 06520, USA; Yale Institute for Global Health, Yale University, New Haven, CT 06520, USA.

出版信息

Cell. 2020 Oct 15;183(2):290-295. doi: 10.1016/j.cell.2020.09.040.

DOI:10.1016/j.cell.2020.09.040
PMID:33064982
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7560117/
Abstract

Vaccines save millions of lives from infectious diseases caused by viruses and bacteria. As the world awaits safe and effective COVID-19 vaccines, we celebrate the progresses made and highlight challenges ahead in vaccines and the science behind them.

摘要

疫苗可预防病毒和细菌引起的传染病,拯救数百万人的生命。在全世界期待安全有效的 COVID-19 疫苗之际,我们庆祝所取得的进展,并强调疫苗及其背后科学所面临的挑战。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2daa/7560117/898272f8b88f/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2daa/7560117/331316c1e223/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2daa/7560117/898272f8b88f/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2daa/7560117/331316c1e223/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2daa/7560117/898272f8b88f/gr2_lrg.jpg

相似文献

1
Why and How Vaccines Work.疫苗为何以及如何发挥作用。
Cell. 2020 Oct 15;183(2):290-295. doi: 10.1016/j.cell.2020.09.040.
2
Coronavirus vaccines get a biotech boost.冠状病毒疫苗获得生物技术助力。
Nature. 2020 Jul;583(7817):647-649. doi: 10.1038/d41586-020-02154-2.
3
Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19.一旦我们有了疫苗,会去接种吗?一项关于接种新冠疫苗意愿的欧洲调查。
Eur J Health Econ. 2020 Sep;21(7):977-982. doi: 10.1007/s10198-020-01208-6.
4
SARS-CoV-2 vaccination-A plea for fast and coordinated action.2019冠状病毒病疫苗接种——呼吁迅速采取协调行动。
Zoonoses Public Health. 2020 Nov;67(7):840. doi: 10.1111/zph.12740. Epub 2020 Jul 1.
5
Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination.通过大规模疫苗接种建立对SARS-CoV-2感染的群体免疫面临的挑战。
Lancet. 2020 Nov 21;396(10263):1614-1616. doi: 10.1016/S0140-6736(20)32318-7. Epub 2020 Nov 4.
6
The COVID-19 vaccine development landscape.2019冠状病毒病疫苗的研发情况。
Nat Rev Drug Discov. 2020 May;19(5):305-306. doi: 10.1038/d41573-020-00073-5.
7
The underdog coronavirus vaccines that the world will need if front runners stumble.如果领先的新冠病毒疫苗出现问题,世界将需要的处于劣势的新冠病毒疫苗。
Nature. 2020 Sep;585(7825):332-333. doi: 10.1038/d41586-020-02583-z.
8
Understanding COVID-19 vaccine efficacy.了解新冠病毒疫苗的效力。
Science. 2020 Nov 13;370(6518):763-765. doi: 10.1126/science.abe5938. Epub 2020 Oct 21.
9
China's coronavirus vaccines are leaping ahead - but face challenges as virus wanes.中国的新冠病毒疫苗进展迅速——但随着病毒减弱面临挑战。
Nature. 2020 Aug;584(7819):17-18. doi: 10.1038/d41586-020-02244-1.
10
The Race to Develop a COVID-19 Vaccine.新冠疫苗研发竞赛。
Am J Nurs. 2020 Oct;120(10):14-15. doi: 10.1097/01.NAJ.0000718556.85319.00.

引用本文的文献

1
Harnessing the Loop: The Perspective of Circular RNA in Modern Therapeutics.利用环状结构:现代治疗学中环状RNA的视角
Vaccines (Basel). 2025 Jul 31;13(8):821. doi: 10.3390/vaccines13080821.
2
Development of COVID-19 Vaccine Candidates Using Attenuated Recombinant Vesicular Stomatitis Virus Vectors with M Protein Mutations.利用具有M蛋白突变的减毒重组水疱性口炎病毒载体开发COVID-19候选疫苗
Viruses. 2025 Jul 30;17(8):1062. doi: 10.3390/v17081062.
3
Mapping the research landscape of immune response in human brucellosis: a bibliometric analysis.
绘制人类布鲁氏菌病免疫反应的研究全景:一项文献计量分析。
Front Microbiol. 2025 Jul 29;16:1583520. doi: 10.3389/fmicb.2025.1583520. eCollection 2025.
4
Novel adjuvant delivery system constructed by alum-emulsion hybrid nanoparticles with TLR9 agonists boosts vaccine immunity.由含TLR9激动剂的明矾-乳液混合纳米颗粒构建的新型佐剂递送系统可增强疫苗免疫。
J Nanobiotechnology. 2025 Jul 1;23(1):472. doi: 10.1186/s12951-025-03560-2.
5
Next-Generation Vaccine Platforms: Integrating Synthetic Biology, Nanotechnology, and Systems Immunology for Improved Immunogenicity.下一代疫苗平台:整合合成生物学、纳米技术和系统免疫学以提高免疫原性
Vaccines (Basel). 2025 May 30;13(6):588. doi: 10.3390/vaccines13060588.
6
Current progress and challenges in the design and development of a successful COVID-19 vaccine.成功研发新冠疫苗过程中的当前进展与挑战
Fundam Res. 2021 Mar;1(2):139-150. doi: 10.1016/j.fmre.2021.01.011. Epub 2021 Jan 26.
7
Immunotherapeutic Approach for Improving the Efficacy of a Novel Subunit Vaccine Against SARS-CoV-2 by Cytotoxic T-Lymphocytes (CTL) Epitopes.通过细胞毒性T淋巴细胞(CTL)表位提高新型SARS-CoV-2亚单位疫苗疗效的免疫治疗方法。
Scientifica (Cairo). 2025 May 26;2025:6025826. doi: 10.1155/sci5/6025826. eCollection 2025.
8
The recent advances in vaccine adjuvants.疫苗佐剂的最新进展。
Front Immunol. 2025 May 13;16:1557415. doi: 10.3389/fimmu.2025.1557415. eCollection 2025.
9
Nanotechnology-based strategies for vaccine development: accelerating innovation and delivery.基于纳米技术的疫苗开发策略:加速创新与交付
Biomater Transl. 2025 Mar 25;6(1):55-72. doi: 10.12336/biomatertransl.2025.01.005. eCollection 2025.
10
Toll-like receptor response to Zika virus infection: progress toward infection control.Toll样受体对寨卡病毒感染的反应:感染控制方面的进展
Npj Viruses. 2025 Mar 13;3(1):20. doi: 10.1038/s44298-025-00102-3.